Clinical Trials and Neuroendocrine Tumours

Please add your voice to our Clinical Trials and Neuroendocrine Tumour (NET) survey.

The Unicorn Foundation wants to see more clinical trials open for NET patients. We also want to understand what barriers stop people from participating in them. Your responses to this survey will help us work with our partners to achieve this and we value your input.
You will probably already have some ideas about clinical trials and we’ll explain more as you work your way through the survey.

One of the barriers to clinical trials in NETs is recruiting patients due to the smaller numbers of diagnosed when comparing to more common cancers. We think that although it is difficult to recruit the appropriate numbers, this difficulty can be overcome with your help. Let us know what your understanding is of how trials work; what would encourage you to participate in a trial; and what would be the best ways to communicate with you about upcoming trials.

The survey will be open for two months and we hope to get a cross section of our group so that we can help to make more informed decisions and encourage more stakeholders to invest in research in our NET Community.

It should only take you 5min-10mins and your assistance will be invaluable, simply click here to get started!

Thank you!

Share this article

Subscribe to our Newsletter

Stay up to date on news and events, clinical trials and new research on neuroendocrine cancers.

Related News

Bringing Together Experts to Improve NET Patient Care: NECA at the 5th NET Preceptorship

NECA at ENETS 2025: Advancing NET Care on the Global Stage

The Australian Cancer Plan

Impact of Nutritional Status on Gastroenteropancreatic Neuroendocrine Tumors (GEP-NET) Aggressiveness

Walk, run, or ride this March4NETs!

For its third year, March4NETs will run throughout March 2026.

Get involved and support the 31,000 Australians living with neuroendocrine cancer.